Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anatomic Stage II Breast Cancer AJCC v8 × tremelimumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Non Small Cell Lung Cancer NSCLC 1 Mesothelioma, Malignant 1 Lung Neoplasms 1 Lung Cancer Metastatic 1 Liver Neoplasms 1 Hydronephrosis 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Follicular 1

Interventions

Taxes 2 Paclitaxel 2 trastuzumab biosimilar HLX02 1 pertuzumab 1 durvalumab 1 Trastuzumab 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiation 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Mastectomy, Segmental 1 Mastectomy 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Genetic Testing 1 Fluorodeoxyglucose F18 1 Drug Therapy 1 Doxorubicin 1 Docetaxel 1 Disulfides 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1 Ado-Trastuzumab Emtansine 1 2C4 antibody 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡